BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27515477)

  • 1. Antibodies against peptides of NMDA-type GluR in cerebrospinal fluid of patients with epileptic spasms.
    Mori T; Takahashi Y; Araya N; Oboshi T; Watanabe H; Tsukamoto K; Yamaguchi T; Yoshitomi S; Nasu H; Ikeda H; Otani H; Imai K; Shigematsu H; Inoue Y
    Eur J Paediatr Neurol; 2016 Nov; 20(6):865-873. PubMed ID: 27515477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome.
    Fukuyama T; Takahashi Y; Kubota Y; Mogami Y; Imai K; Kondo Y; Sakuma H; Tominaga K; Oguni H; Nishimura S
    Epilepsy Res; 2015 Jul; 113():34-43. PubMed ID: 25986190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua.
    Takahashi Y; Mori H; Mishina M; Watanabe M; Fujiwara T; Shimomura J; Aiba H; Miyajima T; Saito Y; Nezu A; Nishida H; Imai K; Sakaguchi N; Kondo N
    Neurology; 2003 Oct; 61(7):891-6. PubMed ID: 14557555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploratory investigation of antibodies to NMDA-type glutamate receptor subunits in serum and cerebrospinal fluid among psychiatric patients with anti-thyroid antibodies.
    Saito T; Chiba Y; Abe K; Hattori S; Katsuse O; Takahashi Y; Suda A
    Heliyon; 2020 Dec; 6(12):e05677. PubMed ID: 33319115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy with myoclonic atonic seizures and chronic cerebellar symptoms associated with antibodies against glutamate receptors N2B and D2 in serum and cerebrospinal fluid.
    Matsuura R; Hamano SI; Ikemoto S; Hirata Y; Suzuki K; Kikuchi K; Takahashi Y
    Epileptic Disord; 2017 Mar; 19(1):94-98. PubMed ID: 28246062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of internalization of NMDA-type GluRs with antibodies to GluN1 and GluN2B.
    Takahashi Y; Nishimura S; Takao E; Kasai R; Enokida K; Ida K; Fukuoka M; Koike T; Omatsu H; Yamaguchi T; Takano S; Yoshida T; Mori H
    J Neuroimmunol; 2020 Dec; 349():577427. PubMed ID: 33091764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay.
    Iizuka M; Nagata N; Kanazawa N; Iwami T; Nagashima M; Nakamura M; Kaneko J; Kitamura E; Nishiyama K; Mamorita N; Iizuka T
    Front Immunol; 2024; 15():1350837. PubMed ID: 38745654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination.
    Takahashi Y; Matsudaira T; Nakano H; Nasu H; Ikeda H; Nakaoka K; Takayama R; Oota M
    J Neuroimmunol; 2016 Sep; 298():71-8. PubMed ID: 27609278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of titers of antibodies against peptides of subunits NR1 and NR2B of glutamate receptor by enzyme-linked immunosorbent assay in psychiatric patients with anti-thyroid antibodies.
    Ikura T; Katsuse O; Chiba Y; Takahashi Y; Fujishiro H; Kamada A; Saito T; Hirayasu Y
    Neurosci Lett; 2016 Aug; 628():201-6. PubMed ID: 27317996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between the level of antibody against peptide of glutamate receptor NR3B subunit in the CSF and cognitive comorbidities of patients with epilepsy.
    Li XY; Hu P; Li QY; Zhang M; Lai QW; Wang X; Fan HB; Yao RQ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):328-337. PubMed ID: 30657574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias.
    Busse M; Kunschmann R; Dobrowolny H; Hoffmann J; Bogerts B; Steiner J; Frodl T; Busse S
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):483-492. PubMed ID: 28176002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the concordance between GluN1-GluN2 heteromer live-cell-based assay and GluN1 monomer biochip kit assay on anti-NMDAR autoantibody detection.
    Tanaka K; Kitagawa Y; Hori K; Kinoshita M; Tanaka M
    J Immunol Methods; 2021 Dec; 499():113150. PubMed ID: 34560071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibodies to glutamate receptor in limbic encephalitis].
    Takahashi Y; Mogami Y; Takayama R; Ikeda H; Imai K
    Brain Nerve; 2010 Aug; 62(8):827-37. PubMed ID: 20714031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients.
    Fujita K; Yuasa T; Takahashi Y; Tanaka K; Sako W; Koizumi H; Iwasaki Y; Yoshida M; Izumi Y; Kaji R
    J Neuroimmunol; 2012 Oct; 251(1-2):90-3. PubMed ID: 22809875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of tau protein levels in the cerebrospinal fluid of children with West syndrome.
    Inoue H; Matsushige T; Hasegawa S; Abe A; Iida Y; Inoue T; Ichiyama T
    Epilepsy Res; 2012 Nov; 102(1-2):8-12. PubMed ID: 22831649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitatory amino acid levels in cerebrospinal fluid of patients with infantile spasms.
    Ince E; Karagöl U; Deda G
    Acta Paediatr; 1997 Dec; 86(12):1333-6. PubMed ID: 9475311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
    Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
    Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
    Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
    Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.